Porton Pharma Solutions Ltd. (SHE:300363)

China flag China · Delayed Price · Currency is CNY
21.43
+0.36 (1.71%)
Mar 10, 2026, 3:04 PM CST
27.03%
Market Cap 11.38B
Revenue (ttm) 3.43B
Net Income (ttm) -1.41M
Shares Out 540.16M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE 91.61
Dividend n/a
Ex-Dividend Date n/a
Volume 7,291,363
Average Volume 8,457,163
Open 20.77
Previous Close 21.07
Day's Range 20.77 - 21.59
52-Week Range 12.31 - 30.40
Beta 0.69
RSI 34.19
Earnings Date Apr 4, 2026

About Porton Pharma Solutions

Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial. It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, production, and supply chain. It also offers crystallization, bio catalysis, metal catalysis, flow chemistry, prep-chromatography, and milling. The company o... [Read more]

Sector Healthcare
Founded 2005
Employees 4,200
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300363
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.